. Author manuscript; available in PMC: 2008 Sep 11.

Published in final edited form as: J Chromatogr A. 2007 Feb 4;1151(1-2):211–215. doi: 10.1016/j.chroma.2007.01.127

Table 2.

Recombination scheme for the anti-TB fractions used to produce the cocktails for synergy evaluation

From the left: cocktail mix number, contents, expected activity in case of no interaction, concentration for the expected activity, detailed concentrations for each fraction.

Cocktails	Ingredients	Expected inhibition (%)	Conc (µg/ml)	Concentrations for each component fraction (µg/ml)

				B₁1	B₁2	B₁3
mix 1	B₁2+B₁3	40	32	-	16.29	15.71
mix 2	B₁1−B₁3	40	32	3.00	8.28	20.72

				B₂1	B₂2	B₂3	B₂4	B₂5	B₂6	B₂7
mix 3	B₂3−B₂6	40	32	-	-	6.28	23.30	0.78	1.64	-
mix 4	B₂3−B₂7	40	64	10.39	10.39	2.90	22.31	3.15	4.47	10.39
mix 5	B₂1−B₂5	80	64	4.54	13.33	8.74	28.43	8.96	-	-

				B₃1	B₃2	B₃3	B₃4	B₃5	B₃6	B₃7	B₃8	B₃9	B₃10
mix 6	B₃6−B₃10	40	32	-	-	-	-	-	8.53	2.82	13.71	4.39	2.55
mix 7	B₃1−B₂8	40	64	22.68	0.50	0.50	0.50	8.66	7.35	8.71	15.10	-	-